A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

NCT02256982 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Unresectable Intrahepatic Cholangiocarcinoma
Resectable Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
PROCEDURE: Surgery
RADIATION: Radiation

Sponsor

Massachusetts General Hospital